Your institution may have access to this item. Find your institution then sign in to continue.
Title
Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer.
Authors
Meier, C R; Derby, L E; Jick, S S; Jick, H
Abstract
The use of angiotensin-converting enzyme (ACE) inhibitors has been linked to a decreased risk of developing cancer, and longer-term use of calcium channel blockers (CCBs) has been associated with an increased risk of developing cancer in general and breast cancer in particular.
Publication
Archives of internal medicine, 2000, Vol 160, Issue 3, p349